RANI · NASDAQ
Rani Therapeutics Holdings (RANI) Stock Price & Fundamentals
Rani Therapeutics Holdings (RANI) closed at $539.95 on Oct 9, 2026, down 0.61% from the previous close of $543.26.
Share price, past year
1Y +36.83%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $539.95 |
| Sep 30, 2026 | $534.23 |
| Aug 31, 2026 | $524.15 |
| Jul 31, 2026 | $506.88 |
| Jun 30, 2026 | $516.98 |
| May 29, 2026 | $496.07 |
| Apr 30, 2026 | $503.03 |
| Mar 31, 2026 | $485.70 |
| Feb 27, 2026 | $442.84 |
| Jan 30, 2026 | $428.46 |
| Dec 31, 2025 | $410.39 |
| Nov 28, 2025 | $387.89 |
| Oct 31, 2025 | $384.72 |
Key statistics
- Market cap
- —
- P/E (TTM)
- —
- EPS (TTM)
- −$0.13
- Revenue (TTM)
- $4.88M
- Net income (TTM)
- −$30.14M
- Shares outstanding
- —
- Dividend yield
- —
- 52-week range
- $384.72 – $546.80
Financials
Rani Therapeutics Holdings reported revenue of $1.63M for fiscal 2025, up 58.85% from fiscal 2024.
Rani Therapeutics Holdings reported a net loss of $29.67M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $1.63M | +58.9% | −$29.67M | −1,817.1% | −$0.45 | −$18.80M |
| FY2024ended Dec 31, 2024 | $1.03M | — | −$30.02M | −2,920.0% | −$1.05 | −$35.76M |
| FY2023ended Dec 31, 2023 | $0.00 | — | −$33.97M | — | −$1.33 | −$52.47M |
| FY2022ended Dec 31, 2022 | $0.00 | −100.0% | −$30.59M | — | −$1.28 | −$48.13M |
| FY2021ended Dec 31, 2021 | $2.72M | +488.1% | −$8.33M | −306.6% | −$0.43 | −$32.75M |
| FY2020ended Dec 31, 2020 | $462.00K | — | — | — | — | −$16.16M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $1.71M | −$7.39M | −$0.04 |
| Q1 FY2026ended Mar 31, 2026 | $1.71M | −$7.03M | −$0.04 |
| Q4 FY2025ended Dec 31, 2025 | $1.46M | −$10.31M | $0.07 |
| Q3 FY2025ended Sep 30, 2025 | $0.00 | −$5.41M | −$0.12 |
| Q2 FY2025ended Jun 30, 2025 | $0.00 | −$6.69M | −$0.18 |
| Q1 FY2025ended Mar 31, 2025 | $172.00K | −$7.26M | −$0.22 |
| Q4 FY2024ended Dec 31, 2024 | $1.03M | −$8.95M | −$0.26 |
| Q3 FY2024ended Sep 30, 2024 | $0.00 | −$6.78M | −$0.24 |
Company profile
- Name
- Rani Therapeutics Holdings, Inc.
- Ticker
- RANI
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 2051 Ringwood Avenue, San Jose, CA 95131
- Incorporated in
- CA
- Fiscal year ends
- December
- SEC CIK
- 0001856725
Recent SEC filings
- Aug 13, 2026
- Aug 13, 2026
- Aug 4, 2026
- Jun 30, 2026
- May 29, 2026
- May 27, 2026
- May 15, 2026
- May 15, 2026
Frequently asked questions
What is Rani Therapeutics Holdings's stock price?
Rani Therapeutics Holdings (RANI) closed at $539.95 on Oct 9, 2026, down 0.61% from the previous close of $543.26.
How much revenue does Rani Therapeutics Holdings make?
Rani Therapeutics Holdings reported revenue of $1.63M for fiscal 2025, up 58.85% from fiscal 2024.
Does Rani Therapeutics Holdings pay a dividend?
Rani Therapeutics Holdings's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Rani Therapeutics Holdings, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures